论文部分内容阅读
氩激光小梁成形术是降低眼压的有效措施之一,但其疗效可能随时间延长而减弱。文献报道,随访3—8个月,成功率为55%—99%,随访5年成功率则为50%。为了评价氩激光小梁成形术的远期效果,本文作者对1981—1982年期间所行氩激光小梁成形术的33例(43只眼)开角型青光眼患者进行了为期2—4年的追踪观察。判断氩激光小梁成形术是否成功的标准是:患者术后在无药物治疗的情况下眼压≤21mmHg,青光眼杯和视野缺损无进展。作者发现17只眼治疗成功,成功率为39%。术后1个月15只眼失败,其中7只眼因药物不能控制眼压而行小梁切除术,这提示氩激光小梁成形术可能损伤小梁,使一些患眼眼压
Argon laser trabeculation is one of the effective measures to reduce intraocular pressure, but its curative effect may be weakened with time. Reported in the literature, followed up for 3-8 months, the success rate was 55% -99%, follow-up 5-year success rate was 50%. To assess the long-term effect of argon laser trabeculoplasty, we performed 33 patients (43 eyes) with open-angle glaucoma under argon laser trabeculoplasty from 1981 to 1982 for a period of 2-4 years Follow up observation. The criteria for determining the success of argon laser trabeculation are: intraocular pressure ≤ 21 mmHg in patients without medication, and no progression in glaucoma cups and visual field defects. The authors found that 17 eyes were successfully treated with a success rate of 39%. 15 eyes failed 1 month after surgery, of which 7 eyes due to the drug can not control intraocular pressure and trabeculectomy, suggesting that argon laser trabeculoplasty may damage the trabeculae, so that some intraocular pressure